Black Women and Ovarian Cancer

Disclaimer: No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

FACT: Early detection of ovarian cancer is critical. However, the symptoms can be very vague, making them difficult to identify in order to receive the appropriate diagnosis and treatment.

What is Ovarian Cancer?

Ovarian cancer is a type of cancer that begins in the ovaries—small, almond-shaped organs located on either side of the uterus. The ovaries are responsible for producing eggs and hormones like estrogen and progesterone. These hormones are responsible for regulating the menstrual cycle and for the development of secondary sex characteristics, such as breast development. Ovarian cancer develops from abnormal cells in the ovaries that become cancerous and grow out of control. If not detected and treated early, they may grow and spread to other parts of the pelvis and abdomen.

Early detection of ovarian cancer significantly improves survival rates; however, the American Cancer Society states that it is often detected in later stages due to its subtle and non-specific symptoms. Continued research and awareness are vital for improving outcomes and potentially reducing the incidence of ovarian cancer.

What are the Symptoms of Ovarian Cancer?

In the early stages, ovarian cancer often does not cause noticeable symptoms. As a matter of fact, these symptoms can feel very vague. They may become apparent as the cancer progresses and begins to spread to other parts of the pelvis or abdomen.

Common symptoms among women with ovarian cancer include:

  • Abdominal bloating or swelling
  • Pelvic pain or discomfort
  • Changes in bowel habits, such as constipation
  • Frequent urination
  • Feeling full quickly when eating

These symptoms can be caused by ovarian cancer or other health issues, so it is important to see your doctor if you experience any of these symptoms consistently.

The Four Stages of Ovarian Cancer

Ovarian cancer is divided into four stages as the American Cancer Society outlines: 

  • Stage I: The cancer is confined to one or both ovaries.
  • Stage II: The cancer has spread to other pelvic tissues, such as the fallopian tubes or uterus.
  • Stage III: The cancer has spread to the abdominal lining or lymph nodes within the abdomen.
  • Stage IV: The cancer has spread to distant organs outside the abdomen, such as the liver or lungs.

What Causes Ovarian Cancer?

The exact cause of ovarian cancer is not well understood, but the Centers for Disease Control and Prevention (CDC) states that several risk factors are known to increase the likelihood of developing the disease. These include genetic mutations (such as in the BRCA1 and BRCA2 genes), a family history of ovarian cancer, and other reproductive conditions like endometriosis. Other factors include hormone replacement therapy, obesity, and reproductive history.

All women are at risk for ovarian cancer, but older people are more likely to be affected by this disease, as the CDC reports. About 90% of people who get ovarian cancer are older than 40 years of age, with the greatest number of cases occurring in women aged 60 years or older. 

What are BRCA1 and BRCA2 genes?

BRCA1 and BRCA2 genes are involved in both ovarian and breast cancer, states the CDC. Under normal conditions, these two genes work to protect people from breast and ovarian cancer. However some mutations in BRCA1 and BRCA2 genes prevent them from working properly. This puts a person at risk for certain types of breast and ovarian cancer.

People are more likely to have mutations in BRCA1 or BRCA2 if they have a strong history of breast or ovarian cancer in their family on either the mother’s or father’s side. Mutations in these genes can be detected through genetic testing.

It is important to note that Black women often face significant barriers in accessing genetic testing. Challenges such as high costs or a lack of health insurance can make testing unaffordable. Additionally, cultural and historical mistrust of the healthcare system, driven by past injustices, may lead to hesitancy around genetic testing. These barriers may prevent many Black women from receiving the genetic testing needed to determine if they have mutations in their BRCA1 or BRCA2 genes. 

Approximately 1.1% of women will be diagnosed with ovarian cancer at some point during their lifetime; however, according to the National Cancer Institute, if a woman has a mutation in the BRCA1 or BRCA2 genes, then her chances of being diagnosed with ovarian cancer by age 70 increases to 30%. About 10% of ovarian cancer cases in the United States occur because of a mutation in the BRCA1 or BRCA2 genes, but the CDC states that ovarian cancer can also be caused by mutations in genes other than BRCA1 and BRCA2. If you are concerned that you may have one of these mutations, you should speak to your healthcare provider about genetic testing.

Black Women and Ovarian Cancer

Research suggests that Black women may face unique challenges related to ovarian cancer, including disparities in diagnosis, treatment, and outcomes. Janet Hildebrand, PhD, explains that Black women are diagnosed with ovarian cancer significantly less than other groups, with about 9.4 Black women being diagnosed per 100,000. Although Black women are not more likely to develop ovarian cancer, Shirley Mei, MD, writes that Black women are 20% more likely to be diagnosed with ovarian cancer at a later stage compared to white women.

As a result of this, Black women with ovarian cancer tend to have poorer survival rates, even when adjusting for stage and treatment, states Joellen Schildkraut, PhD, MPH. The five-year relative survival rate for Black women with ovarian cancer is 41%, whereas the survival rate for white women is 48%. This disparity may be due to a combination of factors, including delayed diagnosis, limited access to healthcare, and differences in the biology of the cancer itself.

Although Black women may have access to screening and preventive measures, they often encounter barriers that hinder early diagnosis and effective treatment. These barriers include, but are not limited to, a lack of:

  • Awareness about ovarian cancer symptoms and risk factors
  • Access to specialized care and genetic counseling
  • Trust in healthcare providers due to historical and systemic racism
  • Health insurance coverage
  • Workplace flexibility and support for medical appointments
  • Transportation to healthcare facilities

Another factor that may contribute to disparities in outcomes is the underrepresentation of Black women in clinical trials for ovarian cancer treatments. This lack of representation can lead to a gap in understanding how treatments affect Black women specifically, potentially leading to less effective care.

Addressing these disparities requires a multi-faceted approach that includes increasing awareness, improving access to care, and strong patient-provider relationships. Self-advocacy may play a large role in managing ovarian cancer. Patients are encouraged to ask questions, seek second opinions, and ensure they fully understand their treatment options. Taking an active role in your healthcare may lead to better outcomes and an improved quality of life. Try to find a friend or a loved one to act as an advocate and support system if at all possible.

Ovarian Cancer Prevention

Ovarian cancer prevention focuses on reducing known risk factors and promoting early detection. While there is no guaranteed method to prevent ovarian cancer, understanding the factors that may reduce risk is essential.

Risk Reduction Strategies

Ovarian cancer risk factors include family history, genetic mutations (such as in the BRCA1 and BRCA2 genes), and personal reproductive history. Recommended strategies by the American Cancer Society and CDC for reducing ovarian cancer risk include:

  1. Genetic Counseling and Testing: Women with a family history of ovarian or breast cancer should consider discussing the possibility of BRCA gene testing with their doctor. Identifying genetic mutations can help in taking preventive measures, such as increased surveillance or risk-reducing surgeries.
  2. Oral Contraceptives: Long-term use of oral contraceptives has been shown to reduce the risk of ovarian cancer. However, this should be discussed with a healthcare provider, as oral contraceptives may have other health implications.
  3. Pregnancy and Breastfeeding: Full-term pregnancies and breastfeeding have been associated with a reduced risk of ovarian cancer.
  4. Surgical Options: Women at high risk for ovarian cancer, particularly those with BRCA gene mutations, may consider prophylactic oophorectomy, or the removal of the ovaries, after completing childbearing. This significantly reduces the risk of developing ovarian cancer , but it also brings about early menopause and other long-term health considerations.
  5. Healthy Lifestyle Choices: Maintaining a healthy diet, regular exercise, and avoiding smoking may help reduce the risk of many cancers, including ovarian cancer.

Ovarian Cancer Screening

Ovarian cancer is often diagnosed at a late stage because, unlike cervical cancer, there are no effective routine screening tests for it. However, earlier detection may be possible with regular pelvic exams and being vigilant about symptoms such as: 

  • Abdominal bloating or swelling
  • Pelvic pain or discomfort
  • Changes in bowel habits, such as constipation
  • Frequent urination
  • Feeling full quickly when eating

These symptoms are often vague and can be mistaken for other conditions, making ovarian cancer difficult to detect early. Women experiencing persistent symptoms should consult a healthcare provider, particularly if they have a family history of ovarian cancer.

Ovarian Cancer Diagnosis

The Mayo Clinic outlines the following diagnostic procedures that may be used if ovarian cancer is suspected:

  • Pelvic Examination: A physical exam where a healthcare provider checks the ovaries and surrounding organs for lumps or other changes.
  • Transvaginal Ultrasound (TVUS): An imaging test that uses sound waves to look at the ovaries and other reproductive organs.
  • CA-125 Blood Test: A test that measures the level of CA-125, a protein that is often elevated in women with ovarian cancer. However, elevated levels can also be caused by other conditions.
  • Biopsy: A procedure in which a sample of tissue is removed and examined under a microscope to check for cancer cells. This is typically done during a surgery to remove a suspicious mass.

Treatment

Treatment for ovarian cancer depends on several factors, including the stage and location of cancer, the patient’s overall health, if a patient plans to become pregnant, and whether the cancer has spread.

Follow-Up after Treatment

Follow-up care is crucial for monitoring recurrence and managing any long-term side effects of treatment. Regular physical exams, imaging tests, and blood tests (such as the CA-125 test) may be part of the follow-up plan.

What Check-Ups Should a Woman Have After Treatment for Ovarian Cancer?

The American Cancer Society recommends the following guidelines for women after treatment for ovarian cancer:

  • First Year: Most women are advised to see their doctors every 2-4 months.
  • Years 2-3: Visits may become less frequent, typically every 4-6 months.
  • Years 4-5: Check-ups may be scheduled every 6-12 months.
  • After Five Years: Annual check-ups should be scheduled.

Women should report any new symptoms, such as pelvic pain, bloating, or changes in bowel or bladder habits, to their healthcare providers immediately.

Ovarian Cancer Research

Research is ongoing to improve the prevention, detection, and treatment of ovarian cancer. Advances in genetic research, targeted therapies, and immunotherapies offer hope for better outcomes. Participation in clinical trials can provide access to cutting-edge treatments and contribute to the advancement of ovarian cancer care.

Clinical Trials

Researchers are continuously exploring new treatments, including targeted therapies that focus on specific genetic mutations and immunotherapies that use the body's immune system to fight cancer. Women with ovarian cancer are encouraged to discuss clinical trial options with their healthcare provider, as they may provide access to new and promising treatments.

For example, the National Cancer Institute sponsored clinical trial is investigating whether removing the fallopian tubes and postponing the removal of the ovaries can effectively and safely reduce the risk of ovarian cancer in women with BRCA1 mutations, compared to removing both the ovaries and fallopian tubes simultaneously. This approach could help women maintain premenopausal hormone levels and delay some of the complications associated with menopause. 

By staying informed and actively participating in their healthcare, women can play a critical role in the fight against ovarian cancer.

For more information, contact the following organizations: 

  • Ovarian Cancer Research Alliance (OCRA)
  • National Ovarian Cancer Coalition (NOCC)
  • Clearity Foundation
  • The Ovarian Cancer National Alliance (OCNA)
  • Teal It Up Foundation
  • National Cancer Institute (NCI)
  • Centers for Disease Control and Prevention (CDC) – Gynecologic Cancer
  • American Cancer Society (ACS)
  • Office on Women’s Health